Navigation Links
Commercial yeasts upgraded with an enzyme for biofuel production
Date:2/24/2009

This release is available in German.

Eckhard Boles, co-founder of the Swiss biofuel company Butalco GmbH and a professor at Goethe-University in Frankfurt, Germany, has discovered a new enzyme which teaches yeast cells to ferment xylose into ethanol. Xylose is an unused waste sugar in the cellulosic ethanol production process. The researchers have recently filed a patent application for their process.

In industrial fermentation processes, the yeast Saccharomyces cerevisiae is commonly used for ethanol production. Current bioethanol production technologies can use only parts of the plants, namely the storage sugars, like glucose, sucrose or starch. However, this technology is in competition with food and feed production. Eckhard Boles, co-founder of the Swiss biofuel company Butalco GmbH and a professor at Goethe-University in Frankfurt, Germany, has therefore searched for ways of teaching the microorganisms to convert waste sugars, xylose and arabinose, into ethanol. Now, Boles and his colleagues have succeeded in genetically modifying industrial yeast strains, thus producing ethanol from xylose in a single step. Having already succeeded in transforming arabinose into ethanol by genetically modified yeast strains, Boles and his team have now found an efficient way to convert most of the plants energy into biofuel.

"Up to now scientists considered it as unpromising to equip yeast with a bacterial enzyme capable of converting xylose", Boles explains, "because all attempts had failed". But he and his team continued trying by exploring the enormous amounts of information in current genetic databases. Step by step they took 12 enzymes from different bacterial organisms and inserted the enzymes into yeast cells. Finally they discovered a new enzyme that even worked in yeast cells from a commercial ethanol plant. In contrast to current cellulosic ethanol technologies the new enzyme can convert xylose in a single step and is not inhibited by other chemical compounds normally present within the yeast cells. The researchers have recently filed a patent application for their process. "This is a break-through in the commercialisation of cellulosic ethanol", comments Boles.

Boles says: "We have successfully demonstrated the conversion of waste sugars into ethanol. However, ethanol is not the best renewable biofuel. There are other alcohols with many more promising properties." Together with his company, Butalco GmbH, Boles is now constructing yeast strains to convert plant waste materials into biobutanol, which is being seen as a more superior alternative fuel than ethanol due to its more favourable chemical and physical properties.


'/>"/>

Contact: Eckhard Boles
e.boles@bio.uni-frankfurt.de
49-697-982-9513
Goethe University Frankfurt
Source:Eurekalert

Related biology news :

1. bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors
2. Commercial aquatic plants offer cost-effective method for treating wastewater
3. MSU technology that converts plant fibers to biofuel commercialized
4. OHSU commercial collaborations have surged
5. Commercialization aim of grant supporting technology that destroys cancer cells
6. Food scientists confirm commercial product effectively kills bacteria in vegetable washwater
7. NOAA proposes rule to prevent commercial harvesting of krill
8. OCAST funds OSU projects with commercial viability
9. IEEE Homeland Security Conference Business Panel to feature experts on technology commercialization
10. UTMB inventions win University of Texas System commercialization awards
11. Computers explain why pears may become brown during commercial storage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 Venture ... by a MichBio member organization. They provide an opportunity to interact with peers, make ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... 2017  ArmaGen, Inc., a privately held biotechnology ... severe neurological disorders, today reported preliminary evidence of ... company,s investigational therapy for the treatment of Hurler ... I, or MPS I). The initial results from ... today at the 13 th annual WORLD ...
Breaking Biology Technology: